Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Common epithelial cancer of the ovary (2).

× No keyword cloud information.

13 in total

1. Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells.

Authors: G B Mills; C May; M Hill; S Campbell; P Shaw; A Marks
Journal: J Clin Invest Date: 1990-09 Impact factor: 14.808

2. TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103.

Authors: S W Lin; M T Lee; F C Ke; P P Lee; C J Huang; M M Ip; L Chen; J J Hwang
Journal: Clin Exp Metastasis Date: 2000 Impact factor: 5.150

Review 3. Calcium-sensing receptor in cancer: good cop or bad cop?

Authors: Bandana Chakravarti; Shailendra Kumar Dhar Dwivedi; Ambrish Mithal; Naibedya Chattopadhyay
Journal: Endocrine Date: 2008-11-15 Impact factor: 3.633

4. The prognostic value of post chemotherapy serum CA 125 in epithelial ovarian cancer.

Authors: M Teeling; P McGing; D N Carney
Journal: Ir J Med Sci Date: 1989-03 Impact factor: 1.568

5. Predicting response to chemotherapy for patients with epithelial ovarian cancer using urinary polyamine excretion patterns.

Authors: F G Lawton; M Griffin; J A Slack; G Blackledge
Journal: Br J Cancer Date: 1990-10 Impact factor: 7.640

6. Phase II evaluation of mitozolomide in ovarian cancer.

Authors: M Harding; D Northcott; J Smyth; N S Stuart; J A Green; E Newlands
Journal: Br J Cancer Date: 1988-01 Impact factor: 7.640

Review 7. The use of monoclonal antibody B72.3 in the management of gynecologic malignancies.

Authors: J Simpson; J Schlom
Journal: Yale J Biol Med Date: 1988 Jul-Aug

8. Sequential cisplatin/cyclophosphamide chemotherapy and abdominopelvic radiotherapy in the management of advanced ovarian cancer.

Authors: J A Green; H M Warenius; R D Errington; S Myint; G Spearing; A J Slater
Journal: Br J Cancer Date: 1988-11 Impact factor: 7.640

9. Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia.

Authors: Kathy Qi Cai; Corrado Caslini; Callinice D Capo-chichi; Carolyn Slater; Elizabeth R Smith; Hong Wu; Andres J Klein-Szanto; Andrew K Godwin; Xiang-Xi Xu
Journal: PLoS One Date: 2009-07-31 Impact factor: 3.240

10. Specific targeting and toxicity of sulphonated aluminium phthalocyanine photosensitised liposomes directed to cells by monoclonal antibody in vitro.

Authors: J Morgan; A G Gray; E R Huehns
Journal: Br J Cancer Date: 1989-03 Impact factor: 7.640